Cliff Asness's VNDA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 1.6 M shares of Vanda Pharmaceuticals Inc. (VNDA) worth $11.08 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 28 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in VNDA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 976,570 shares. Largest reduction occurred in Q4 2025, reducing 41,460 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Vanda Pharmaceuticals (VNDA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vanda Pharmaceuticals (VNDA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +976,570 | Add 155.75% | 1.6 M | $6.91 |
| Q4 2025 | -41,460 | Reduce 6.20% | 627,006 | $8.82 |
| Q3 2025 | +532,742 | Add 392.52% | 668,466 | $4.99 |
| Q2 2025 | +84,164 | Add 163.24% | 135,724 | $4.72 |
| Q1 2025 | +1,581 | Add 3.16% | 51,560 | $4.59 |
| Q4 2024 | -15,944 | Reduce 24.19% | 49,979 | $4.79 |
| Q3 2024 | -9,966 | Reduce 13.13% | 65,923 | $4.69 |
| Q2 2024 | +48,945 | Add 181.65% | 75,889 | $5.65 |
| Q1 2024 | +10,699 | Add 65.86% | 26,944 | $4.11 |
| Q4 2023 | +16,245 | New Buy | 16,245 | $4.22 |
| Q3 2019 | -17,911 | Sold Out | 0 | $0.00 |
| Q1 2019 | +3,916 | Add 27.98% | 17,911 | $18.42 |
| Q4 2018 | +13,995 | New Buy | 13,995 | $26.15 |
| Q1 2018 | -11,896 | Sold Out | 0 | $0.00 |
| Q3 2017 | -13,477 | Reduce 53.12% | 11,896 | $17.91 |
| Q1 2017 | +11,400 | Add 81.59% | 25,373 | $13.99 |
| Q4 2016 | +13,973 | New Buy | 13,973 | $15.96 |
| Q1 2015 | -12,413 | Sold Out | 0 | $0.00 |
| Q4 2014 | -31,900 | Reduce 71.99% | 12,413 | $14.34 |
| Q2 2014 | -30,200 | Reduce 40.53% | 44,313 | $16.18 |
| Q4 2013 | +39,413 | Add 112.29% | 74,513 | $12.41 |
| Q3 2013 | +20,200 | Add 135.57% | 35,100 | $10.97 |
| Q2 2013 | +14,900 | Add 0.00% | 14,900 | $8.05 |
Cliff Asness's Vanda Pharmaceuticals Investment FAQs
Cliff Asness first purchased Vanda Pharmaceuticals Inc. (VNDA) in Q2 2013, acquiring 14,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Vanda Pharmaceuticals Inc. (VNDA) for 28 quarters since Q2 2013.
Cliff Asness's largest addition to Vanda Pharmaceuticals Inc. (VNDA) was in Q1 2026, adding 1,603,576 shares worth $11.08 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 1,603,576 shares of Vanda Pharmaceuticals Inc. (VNDA), valued at approximately $11.08 M.
As of the Q1 2026 filing, Vanda Pharmaceuticals Inc. (VNDA) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Vanda Pharmaceuticals Inc. (VNDA) was 1,603,576 shares, as reported at the end of Q1 2026.